Novel compounds and methods for their production

Details for Australian Patent Application No. 2007319014 (hide)

Owner Biotica Technology Limited

Inventors Martin, Christine

Agent Davies Collison Cave

Pub. Number AU-A-2007319014

PCT Pub. Number WO2008/056188

Priority 0622342.4 09.11.06 GB; 0720875.4 24.10.07 GB

Filing date 9 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 35/00 (2006.01) Antineoplastic agents

C07D 225/06 (2006.01) Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/056188 Priority application(s): WO2008/056188

16 September 2010 Assignment before Grant

  Biotica Technology Limited The application has been assigned to Bristol-Myers Squibb Company

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007319015-18, 21-didesoxymacbecin derivatives for the treatment of cancer

2007319013-Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)